Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Cognitive and Electrophysiological Assessment of Non-Invasive Temporally-Interfering Electric Fields Stimulation (TIEFS) (TIEFS)

16 de junho de 2026 atualizado por: University of California, Davis

The goal of this clinical trial is to learn how a non-invasive brain stimulation method called Temporally Interfering Electric Fields Stimulation (TIEFS) affects brain activity and thinking in adults. TIEFS uses electrical currents applied to the scalp to influence brain activity without surgery.

The main questions this study aims to answer are:

  • How does TIEFS change brain signals measured with brain recordings?
  • Does TIEFS affect thinking abilities such as memory, language, movement, or perception?
  • Is TIEFS safe and well tolerated when used in people?

This study includes two groups of participants. One group includes adults with epilepsy who are already undergoing specialized brain monitoring as part of their medical care. The other group includes healthy adults with no history of seizures.

Participants will:

  • Receive brief sessions of TIEFS using electrodes placed on the scalp
  • Complete computer-based tasks that test memory, attention, language, or movement. Answer questions about how the stimulation feels
  • Have brain activity recorded during the study

Each study visit lasts up to three hours and may occur in one or two sessions. Information from this study may help researchers better understand the human brain and support the development of future non-invasive brain stimulation treatments.

Visão geral do estudo

Status

Recrutamento

Condições

Tipo de estudo

Intervencional

Inscrição (Estimado)

15

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

    • California
      • Sacramento, California, Estados Unidos, 95817
        • Recrutamento
        • University of California Davis Medical Center
        • Contato:
        • Investigador principal:
          • Nigel P Pedersen, MBBS

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  • Adult patients (age 18-65 years of age) undergoing an intracerebral electrophysiology study for epilepsy pre-surgical evaluation are eligible for inclusion.
  • For healthy control subjects are also eligible for inclusion (Scalp EEG measurements).
  • Participants must be able to sufficiently speak and understand English or Spanish for consent and be able to understand and complete cognitive tasks.
  • All subjects must have the ability to give valid informed consent.

Exclusion Criteria:

  • No pregnant women will be recruited.
  • People with implanted electrical devices such as Deep Brain Stimulation devices or Pacemakers.
  • No prisoners will be recruited.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: Não randomizado
  • Modelo Intervencional: Atribuição sequencial
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Comparison of Active vs Sham TIEFS Stimulation in SEEG patients
This arm involves a within-subject comparison of different frequencies of active TIEFS stimulation and sham stimulation, all within the same session. Patients will already have been admitted to SEEG surgery, and will be approached while still having the electrodes implanted. Each participant will receive multiple types of stimulation at different envelope frequencies (ranging from 1-130 Hz). During the session, electrodes will be placed on the scalp to administer TIEFS at varying frequencies. Each frequency will be tested in separate trials within the session, with multiple trials per frequency. The results from these trials will be averaged to determine the overall impact of each frequency on brain activity (measured through SEEG) and/or cognitive functions (evaluated using tasks related to memory, language, motor function, and perception). Sham stimulation will also be delivered within the same session, and participants will be blinded to the type of stimulation (active vs sham).
Temporal Interference Electrical Stimulation (TIEFS) is a non-invasive brain stimulation technique that uses two high-frequency electrical fields (>1 kHz) to generate an interference pattern at a specific brain region, creating a low-frequency envelope (Δf = f2 - f1) at the target depth. Unlike traditional stimulation methods, which affect only superficial brain regions, TIEFS can reach deeper structures without the need for implanted electrodes. The stimulation is applied through scalp electrodes. It has the potential for targeted brain interventions in both functional studies and clinical applications for neurological conditions.
Experimental: Comparison of Active vs Sham TIEFS Stimulation in Healthy Subjects
This arm involves a within-subject comparison of active and sham TIEFS stimulation in healthy control subjects. Participants will receive both active and sham stimulation in a single session, with different frequencies of TIEFS applied during active stimulation. The goal is to measure the changes in brain activity using EEG and assess the impact of TIEFS on cognitive functions such as memory, motor function, language, and perception. Participants will be blinded to the type of stimulation they are receiving during the session.
Temporal Interference Electrical Stimulation (TIEFS) is a non-invasive brain stimulation technique that uses two high-frequency electrical fields (>1 kHz) to generate an interference pattern at a specific brain region, creating a low-frequency envelope (Δf = f2 - f1) at the target depth. Unlike traditional stimulation methods, which affect only superficial brain regions, TIEFS can reach deeper structures without the need for implanted electrodes. The stimulation is applied through scalp electrodes. It has the potential for targeted brain interventions in both functional studies and clinical applications for neurological conditions.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Brain activity changes during Stimulation
Prazo: Measurements will be recorded throughout the stimulation session (lasting up to 90 minutes), with data collected before, during, and immediately after each stimulation.
This outcome measures the changes in brain activity, either measured through scalp EEG electrodes (in Healthy Participant controls), or intracranial stereotaxic EEG electrodes (for SEEG pre-surgical evaluation epilepsy patients). Local field potential (LFP) power and EEG power in response to active TIEFS stimulation will be compared to sham stimulation. Electrical signals recorded from the brain reflect neural activity. Intracranial signals will be measured across different locations in the brain using implanted SEEG electrodes. Additionally, SEEG electrodes may have tetrodes tips to capture single neuron activity. We will compare how the brain's electrical activity changes during active TIEFS at various frequencies and during the sham stimulation to assess the impact on brain and neural function.
Measurements will be recorded throughout the stimulation session (lasting up to 90 minutes), with data collected before, during, and immediately after each stimulation.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Nigel P Pedersen, MBBS, University of California Davis, School of Medicine, Neurology Department

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

16 de abril de 2025

Conclusão Primária (Estimado)

15 de abril de 2027

Conclusão do estudo (Estimado)

15 de abril de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

16 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de junho de 2026

Primeira postagem (Real)

23 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

23 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Outros números de identificação do estudo

  • 2226959

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

Upon publication, anonymized individual participant data (IPD) will be shared as part of the supplementary materials. The shared data will include EEG recordings, cognitive task results (memory, language, motor, perception), and stimulation parameters (active vs sham, frequencies). All IPD will be de-identified, with personal identifiers removed to ensure confidentiality and compliance with HIPAA. The de-identified data will be made available through a repository or data-sharing platform, accessible to qualified researchers for scientific and educational use only.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Sim

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever